Back to today’s briefing

Story perspectives

New Drug Promises Protection Against Diabetic Eye Damage

5/8/2025

50 10

Summary

Story summary

New research from Johns Hopkins Medicine reveals a troubling link between hypoglycemia and diabetic retinopathy, as low blood sugar raises hypoxia-inducible factor (HIF) levels, compromising the blood-retinal barrier. However, the experimental drug 32-134D shows promise by blocking HIF and safeguarding retinal health, underscoring the urgent need for targeted therapies in patients facing blood sugar fluctuations.

1 of 1

Story summary

New research from Johns Hopkins Medicine reveals a troubling link between hypoglycemia and diabetic retinopathy, as low blood sugar raises hypoxia-inducible factor (HIF) levels, compromising the blood-retinal barrier. However, the experimental drug 32-134D shows promise by blocking HIF and safeguarding retinal health, underscoring the urgent need for targeted therapies in patients facing blood sugar fluctuations.